CUENasdaqPharmaceutical PreparationsFiscal year ends December 31
Cue Biopharma, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$16.08−0.63 (-3.77%)
Close on Oct 19, 2026
- Market cap
- $101.96M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Cue Biopharma's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Sep 20, 2026 | Sep 21, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 14, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 14, 2026 | Aug 14, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 27, 2026 | Aug 3, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 9, 2026 | Jul 10, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 1, 2026 | Jun 3, 2026 | SEC EDGAR |
| Current report | 8-K | May 29, 2026 | Jun 2, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 1, 2026 | May 21, 2026 | SEC EDGAR |
| Current report | 8-K | May 14, 2026 | May 14, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 14, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 27, 2026 | May 1, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 22, 2026 | Apr 22, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 13, 2026 | Apr 13, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 1, 2026 | Apr 7, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 23, 2026 | Mar 27, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Mar 16, 2026 | Mar 16, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 16, 2026 | Mar 16, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 16, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 18, 2026 | Feb 18, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 9, 2026 | Feb 12, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 19, 2025 | Dec 19, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 24, 2025 | Nov 24, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 17, 2025 | Nov 20, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 12, 2025 | Nov 12, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 12, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 6, 2025 | Nov 6, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 26, 2025 | Sep 29, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 12, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 12, 2025 | Aug 12, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 30, 2025 | Jul 1, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 4, 2025 | Jun 10, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 12, 2025 | SEC EDGAR |
| Current report | 8-K | May 12, 2025 | May 12, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 3, 2025 | Apr 25, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 14, 2025 | Apr 15, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 10, 2025 | Apr 14, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 31, 2025 | Mar 31, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 31, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 10, 2025 | Mar 12, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 14, 2024 | SEC EDGAR |